gene resulting in the secretion from various ceU types including thymocytes of soluble H-2K" molecules. Despite the presence of H-2K k antigen, these mice were stiU able to generate an H-2Kk-specific T -ceU response. This response was comparable to that produced by nonnallittermates when stimulated with ceUs expressing membrane H-2K k in a mixed Iymphocyte reaction. In contrast, only transgenic mice failed to generate a cytolytic T-ceU response to soluble H-2K k antigen expressed by recombinant vaccinia virus and presented by the 8-21)1> molecule. These data imply the presence of two populations of aUoreactive cytolytic T ceUs. A smaU fraction of T ceUs recognizes aUoantigen as antigenic peptide(s) presented by other ouQor histocompatibility complex dass I molecules and toIerance can be induced in this popubltion by soluble aUoantigen. Tbe ouQority of T ceUs, however, require the whole ceU membrane-expressed dass I molecule for recognition. This population is not afrected by toIerance induction to the soluble ouQor histocompatibility complex dass I molecule.
In contrast to antibodies that can bind to soluble antigens such as free virus, receptors ofT lymphocytes only recognize foreign antigens that are associated with a major histocompatibility complex (MHC) moleeule on a cell membrane (1) . This "MHC restricted antigen recognition" has become more understandable since the elucidation of the structure of a human MHC class I antigen, which has revealed a putative binding groove for antigen fragments (2) . It is generally accepted that protein antigen (for instance, viral proteins) are processed by infected cells and presented to cytotoxic T lymphocytes (CTLs) by class I moleeules (3) . In the case of alloreactive responses, such as transplant rejections, it is still unclear whether processing and presentation of class I peptides by other class I moleeules is aprerequisite for recognition by CTLs (4) (5) (6) (7) . If the number of alloreactive CTLs responding to a processed form of class I were a substantial fraction of the total number of CTLs reacting with class I antigen, this would have major implications for the induction of tolerance to class I antigens and on the modulations of transplant rejections. To study this question in more detail, we have recently designed a transgenie mouse model to test the influence of membrane-bound versus soluble alloantigen on the induction of tolerance and selection of the T-cell repertoire (8) .
The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
1762
Transgenie (H-2 b X H-2 d )F1 mice were established carrying integrated copies of a modified H-2K k gene, which led to secretion of soluble H-2Kk antigen by various cell types including thymocytes. Soluble H-2K k was present in the sera of the transgenie animals (200 nglml). In spite of this, the transgenie mice were able to generate H-2K k -specific CTL responses when stimulated with cell membrane-bound H-2K k antigens (8) . We have now analyzed the CTL responses of these animals to soluble H-2Kk by using either cells or recombinant vaccinia virus expressing soluble H-2Kk for immunization. We show here that normal mice immunized in such a way can mount a CTL response specific for an H-2Kk fragment and restricted by H-2Db. However, transgenie mice expressing soluble H-2K k are tolerant to MHC class I presented H-2Kk peptides.
MATERIALS AND METHODS
Construction of the Modified H-2K" cDNA. A complete H-2K k cDNA was obtained by recombination oftwo mutant H-2K k cDNA clones (9): a 920-base-pair (bp) Ava 11/ BamHI fragment ofpcDk-l contained the cDNA part 3' to the Ava 11 site and a 300-bp Ava II/BamHI fragment of pcDk-6 contained the cDNA part 5' to the Ava 11 site. These two fragments were cloned into the BamHI site of pUCI9. The H-2Kd cDNA, in contrast to H-2Kk, contains a HindIll site exactly 3' of the a3 domain coding region appropriate for the insertion of a stop codon. Hence, the PsI I/BamHI 3' fragment of the H-2K k cDNA was replaced by the same fragment from an H-2K k cDNA (obtained from P. Kourilsky, Paris). Insertion of a 22-bp stop codon into the HindIll site led to the modified H-2Kk cDNA C70. This was subsequently cloned into an expression vector containing the cytomegalovirus promoter and simian virus 40 poly(A) site (10) .
Construction of Recombinant Vaccinia Virus. The modified H-2Kk cDNA C70 was cloned into the BamHI site of the vaccinia virus recombinant vector CS43. To improve yield of plasmid DNA a 2.0-kbp HindIII/Xho I fragment of pGS62 (11) containing the vaccinia virus thymidine kinase gene driven by the 7.5-kbp promoter was inserted by blunt-end ligation into vector pUC9 cut with EcoRI and HindIll resulting in a plasmid, pCS43. Construction of the recombinant vaccinia virus followed established procedures (12) using the vaccinia virus strain Copenhagen and its temperaturesensitive mutant ts7 (13) . Recombinant vaccinia virus containing the modified H-2K k cDNA was termed VacKkTM-.
CeU Culture and Transfection of CeUs. The fibroblast cell lines 1T22-6 (H-2 q ) and 3T3 (H-2 d ) were used for DNA transfeetions. Cell culture conditions, DNA transfeetion, and Abbreviations: CTL, cytotoxic T lymphocyte; MHC, major histocompatibility complex; MLR, mixed lymphocyte reaction; IL-2, interleukin 2.
analysis of transfectants by immunoprecipitation with monoclonal antibodies and gel electrophoresis were performed as described (14) .
Generation of CTLs. Transgenic mice or nontransgenic littermates were immunized either with 5 x 10 7 transgenic spleen cells subcutaneously or with 5 x 10 7 plaque-forming units of recombinant vaccinia virus or wild-type virus Copenhagen intravenously. After 3-6 weeks, immune spleen cells (5 x lW cells per ml in 24-well culture plates) were restimulated for 5 days in vitra with spleen cells oftransgenic mice (2.5 x Hf cells per ml). The CTL population was expanded for another 3 days with 25 units per ml of recombinant interleukin 2 (lL-2). Alloreactive CTLs were generated in mixed Iymphocyte cultures as described (14) .
Target CeIIs and Cytolytic Assays. IC9 fibrosarcoma cells (15) were infected with 1 plaque-forming unit per cell of vaccinia virus strain Copenhagen. After 2 hr, the inoculum was removed, fresh medium was added, and cells were incubated ovemight (12-18 hr). Target cells were treated with trypsin, labeled for 90 mln with Na2Cr04, and used in a 4-hr standard chromium release assay (14) .
RESULTS
Construction and Expression of the Modified H-2K k cDNA. To test the putative antigenic ditTerence between transmembrane and soluble c1ass I protein, the appropriate cell transfectants and a recombinant viral vector were prepared. The modified H-2K k cDNA C70, which resulted in a secreted H-2K k antigen, was constructed in two consecutive steps (Fig. U) . First, a Pst 1/ BamHI fragment ofthe H-2K k cDNA was replaced by the same fragment of an H-2K d cDNA to introduce the HindIll restriction enzyme site exactly 3' ofthe region coding for the a3 domain. In the second step, this HindlII site was used to insert a stop codon. The resulting modified cDNA encodes the signal sequence and the three outer domains of the H-2K k antigen. There are four amino acid ditTerences at the carboxyl-terminal end of the a3 domain in comparison to the wild-type H-2Kk introduced by the H-2K d cDNA. The construct, called C70, was then c10ned either into the expression vector pL31 containing the cytomegalovirus promoter and the simian virus 40 poly(A) site in pUC19 (10) (pC70), or into the vaccinia virus recombination vector CS43. The recombinant plasmid CS43-C70 was used together with Copenhagen strain DNA to transfect CVl cells infected with the ts7 mutant strain of Copenhagen. The recombinant vaccinia virus VacKkTM-containing the modified H-2K k cDNA was selected after a temperature shift from 33°C to 39.5°C in the presence of BrdUrd (13) .
The modified H-2Kk cDNA containing the stop codon 3' of the region coding for the a3 domain (pC70) was transfected into IT22-6 cells. The resulting transfectants were screened for expression of mRNA in a dot blot using an H-2Kk-specific oligonucleotide (16) . Positive cell clones were characterized by immunoprecipitation with monoclonal anti-H-2K k antibodies and subsequent analysis by NaDodS04/PAGE. The antibody Hl00-27.55 (17) precipitated the C70 antigen from the celllysate as weil as from the cell supematant (Fig. IB,  lanes 1 and 2) . The antigen was found to be associated with ßl-microglobulin. The C70 antigen could also be precipitated with three other monoclonal antibodies, H-142-23, Hl00-5 (17) , and RI-9.6 (18) that have been shown to react with different epitopes on the H-2K k molecule. Therefore, we conclude that the exchange of the four amino acids in the carboxyl-terminal end of the a3 domain did not lead to a detectable alteration in the H-2Kk antigen. However, the introduction of a stop codon into the HindIll site led to an H-2K k antigen that lacked the transmembrane and cytoplasmic regions, resulting in secretion. The modified H-2K cDNA C70 was cloned in the expression vector pL31 containing the cytomegalovirus promoter region and the simian virus 40 poly(A) site. The resulting plasmid pC70 was transfected into IT22-6 fibroblasts. Transfectants were labeled with pSSjmethionine for 2 hr and were solubilized. Antigens in the ceillysate (Iane 1) and the cell supematant (lane 2) were precipitated with the monoclonal anti-H-2Kk antibody H100-27.55 and analyzed by NaDodS04/PAGE. The C70 DNA was also cloned in a recombinant vaccinia virus vector and IT22-6 cells were infected with either the wild-type or the recombinant vaccinia virus for 36 hr. Labeling of cells and immunoprecipitation were done as described above. Lanes 3 and 4. Iysate and supematant material from wild-type infected cells; lanes 5 and 6, material from cells infected with VacKkTM-. In lanes 1 and 5, the C70 antigen migrates according to an apparent molecular weight (MW) of36.000 in association with ß2-microglobulin <ß2m). In the cell supematant of the transfectants (Iane 2), secreted C70 antigen exhibits an apparent molecular weight of 39,000.
IT22-6 cells were infected with 10 plaque-forming units per cell of either wild-type vaccinia virus strain Copenhagen or with recombinant virus VacKkTM-for 1 hr. After an infection period of 36 hr, cells were labeled for 2 hr with [3 5 S]methionine and were then solubilized. As shown in Fig.  IB , the C70 antigen, associated with ß2-microglobulin, could be seen in Iysates of cells infected with recombinant virus VacKkTm-after immunoprecipitation with the antibody H100-27.55 (Fig.IB, lane 5) . Apparently, the C70antigen was not !Iecreted in sufficient amounts for detection in cell supematant (lane 6). Asexpected,the C70 antigen was not detected in lysates and supernatants of cells infected with wild-type virus (lanes 3 and 4) . Fig. 2A , the restimulated CTLs obtained from nontransgenic littermates could only lyse transfectarits· expressing both the H-2Db and the C70 antigens, whereas CTLs obtained from transgenic mice could not lyse any ofthe target Proc. Natl. Acad. Sei. USA 87 (1990) cells (Fig. 2B) . Such effector cells, which apparently react with soluble H-2k k restricted by the H-2Db molecule, were not detectedin mixed lymphocyte reactions (MLRs) from nontransgenie mice stimulated in a primary response by either spleen cells oftransgenic mice expressing thesoluble H-2K k (Fig. 2C) or by spleen cells of B10.BR (H_2K k ) mice (Fig. W) expressing membrane-bound H-2Kk. Target cells expressing the intact membrane-associated H-2K k antigen without the H-2D b antigen were lysed by CTLs generated from both types of mice by stimulation with B10.BR spleen cells in vitro (Fig. 2 D and E) .
It has been shown that class I antigens can be processed by cells and that peptides of this antigen can be presented by other class I molecules (4) . Therefore, the IC9 fibrosarcoma cellline, which expresses only H-2D b as a class I antigen (15), was trarisfected with the cOfllplete H-2K k gene (15) to determine whether such cells could create the target structure for the CTL pOpulation reacting with the soluble H-2K k in an H-2Db restricted fashion. This CTL population, which was obtained from nontransgenic littermates as described above, could indeed react with IC9 cells expressing the transfected H-2K k antigen, butit could not lyse untransfected IC9 cells or IC9 expressing the H-2Kd antigen· (15) ( Table 1 ). This result enabled us to localize the H-2K k fragment that is associated with the H-2Db antigen. IC9 transfectants were used that expressed H~2Kk/H-2Kd hybrid antigeris (15) . 
BR (E).
Curves indicate resultsof the analysis of one representative mouse. Ten mice (A and B) or four mice (C-E) were analyzed. Values indicate results ofthe analysis of one representative mouse. Eight mice were tested individuaIly. The percentages of lysis are mean values of triplicate wells analyzed. E/T, effectQr/target cell ratio. The IC9 fiblVsarcoma line expresses only H-2Db as a class I antigeri. CTLs were generated as described in the legend to Fig. 2. soluble H-2Kk. MHC class I molecules expressed by vaccinia virus vectors have been successfully applied for the generation of CTL responses to alloantigen (20) . Irradiated spleen cells of transgenic animals were used for restimulation in vitro 3-6 weeks later. CTLs were expanded with recombinant IL-2 as mentioned above. CTL populations isolated from nontransgenic Iittermates could Iyse IC9 cells expressing the H-2K k antigen (Fig. 3A) . CTL populations obtained from transgenic mice did not show this activity (Fig. 3B) . The same results were obtained with the above-mentioned 3T3 transfectaJits as targets (data not shown). On the other hand, if spleen cells from mice immunizedwith recombinant vaccinia virus VacKkTM-were tested 6-8 days after priming for their ability to Iyse wild-type vaccinia virus-infected target cells, no difference could be observed in the degree of Proc. Natl. Acad. Sei. USA 87 (1990) 1765 specific lysis by transgenic and nontransgenic animals ( Fig.  3 C and D) . We can, therefore, conclude that nontransgenic Iittermates can res pond to recombinant vaccinia virus in activating CTLs specific for an H -2K k fragment in association with H-2D b . Transgenic mice, however, are tolerant to this target structure. Evidence for effective immunization of both types of mice was demonstrated by the primary in vivo anti-vaccinia virus response.
DISCUSSION
We have recently reported that transgenic mice expressing a foreign class I antigen in soluble form could still react with the same high frequency of CTL precursors to the membranebound alloantigen as normal mice (8) . We could, however, not exclude that the lack of tolerance toward the membrane antigen was based on the fact that the concentration of the antigenic protein in the serum (200 ng/m1) might have been insufficient to induce any tolerance. We have therefote extended the analysis of these transgenic mice to study their reactivity to the soluble form of the class I antigen. H-2K k -specific, H-2Db-restricted CTLs were induced in nontransgenic Iittermates by immunization with either spleen cell~ of transgenic mice or by recombinant vaccinia virus expressing a soluble form of the H-2K k antigen. A peptide fragment of the a1 domain of H-2Kk is recognized in association with H-2D b but not with H-2Kb under these conditions. The observed specific cytolytic activity is smaller than the one resuIting from a primary anti-H-2Kk MLR and requires both in vivo priming and re stimulation in vitro.
Our results confirm that normal mice can respond in two ways to MHC class I antigens: CTLs can be· generated reacting either with an intact class I antigen (H-2Kk) most likely associated with self peptides (21) or to a peptide fragment ofthis class I antigen (H-2Kk) in association with a membrane-bound class I antigen, such as H-2D b (4-7). The mice transgenie for the soiuble H-2K k are still reactive toward the membrane-bound H-2Kk but they are clearly tolerant for H-2Kk peptide(s).
These findings have three major implications. First, soluble class I antigens cannot induce tolerance by direct binding to the receptors of T cells reactive with the intact form of the membrane-associated antigen. It has been shown that soluble class I antigen could interfere with the stimulation of an a1loreactive T-cell hybridoma in vitro (22) . This T-cell hybridoma was reactive to the membrane-bound H-2Kb antigen independent of selfMHC proteins. However, soluble H-2Kb moleeules could only inhibit stimulation ofthe T-cell hybridoma under suboptimal conditions using H_2Kbm mutant antigens. Therefore, these data do not contradict our in vivo results.
Second, MHC moleeules can appear in two distinct antigenie structures. They can either present peptides themselves or they can be processed and presented in peptide form by self MHC molecules. CTLs generated in a primary MLR can Iyse transfectants expressing the relevant class I antigen irrespective of the haplotype of the transfected celliine (14, 19) . Thus, the intact class I antigen is essential for recognition. On the other hand, CTLs that react with class I peptides associated with self class I moleeules have been described in several systems (4-7). However, the percentage of these T cells must be low within the a1loreactive CTL precursor population, because no CTLs could be found specific for soluble H-2K k in association with H-2D b in primary anti-BI0.BR bulk cultures. Only bl immunization with transfectants expressing soluble H-2K or with recombinant vaccinia virus could this H-2K k -specific H-2Db-restricted response be obtained. The transgenie mice are tolerant for this type of T -cell specificity but can nevertheless res pond with a high CTL precursor frequency in a primary anti-H-2Kk MLR that is indistinguishable from normal mice (8) .
Third, an additional aspect of this work is related to the finding that tissue-specific, nonthymic expressed class I antigens in transgenie mice can lead to tolerance to this class I protein (23, 24) . In the two systems that have currently been described, usage of an insulin promoter resulted in expression of H-2Kb in the pancreas (23) , while a metallothionein promoter caused expression in the liver (24) . However, it has been suggested that the observed tolerance could still be based on a thymic event. Class I antigens could be shedded from the respective tissue, taken up by cells migrating to the thymus, and presented by self class land 11 molecules. Our results contradict this suggestion. Even if peptides of the class I antigens that are expressed extrathymically could be presented in the thymus, only the small fraction of the a1loreactive CTL precursor pool that is specific for a class I peptide could be made tolerant. The majority of a1loreactive CTL precursors reacting with the intact class I antigen Proc. Natl. Acad. Sei. USA 87 (1990) should, however, be unaffected unless extrathymic tolerance mechanisms function.
